Untargeted Metabolomics Reveals the Potential Antidepressant Activity of a Novel Adenosine Receptor Antagonist

Depression is the most common mental illness, affecting approximately 4.4% of the global population. Despite many available treatments, some patients exhibit treatment-resistant depression. Thus, the need to develop new and alternative treatments cannot be overstated. Adenosine receptor antagonists...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Arnold Petrus, Lindeque, Jeremie Zander, van der Walt, Mietha Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000263/
https://www.ncbi.nlm.nih.gov/pubmed/35408500
http://dx.doi.org/10.3390/molecules27072094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000263/
https://www.ncbi.nlm.nih.gov/pubmed/35408500
http://dx.doi.org/10.3390/molecules27072094

Ejemplares similares